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Abstract 
Objective: The aim of this prospective study was to estimate the prevalence and risk factors 
for maternal anaemia and low birth weight in pregnant women living in Maharashtra state, 
India.  
Study design: Prospective study 
Methods: Women between 3 to 5 months of pregnancy were recruited from 34 villages 
based in Maharashtra state. Baseline data collection, anthropometric measurements and 
blood investigations were performed. Participants were followed-up to record birth weight. 
Results: In total, 303 women were eligible, and 287 (95%) provided data. 77% were 
anaemic defined as haemoglobin less than 11.0 g/dL at the time of recruitment, with a mean 
corpuscular volume (MCV) of 80.5 fl/cell, (standard deviation: 7.22, range: 53.4 to 93.8). 
Increased risk of anaemia was seen in women with consanguineous marriages (odds ratio 
(OR): 2.41, 95% Confidence Interval (CI): 1.16 to 5.01, p=0.01) after adjustment for potential 
confounding factors. Post-delivery data from full-term singleton live births demonstrated a 
7% prevalence of low birth weight. Consanguineous marriage was a major risk for low birth 
weight (OR: 4.10, 95% CI: 1.25 to 13.41, p=0.02). The presence of maternal anaemia during 
3 to 5 months of pregnancy was associated with lower risk of low birth weight (unadjusted 
OR: 0.34, 95% CI: 0.13 to 0.92, p= 0.03).   
Conclusion: About 30% of our study participants were in a consanguineous marriage, 
which was identified as a potentially avoidable risk factor for both anaemia and low birth 
weight.  
 
Abbreviations: ANC, Antenatal Care; BMI, Body Mass Index; BP, Blood Pressure; CBC, 
Complete Blood Count; g/dL, Grams Per Decilitre; Haemoglobin; Hb, HMF, Halo Medical 
Foundation; IFA, Iron Folic Acid; LBW, Low Birth Weight; MAS, Maharashtra Anaemia 
Study; MCV, Mean Corpuscular Volume; MUAC, Mid-upper arm circumference; NFHS, 
National Family Health Survey; RBS, Random Blood Sugar; VHW, Village Health Worker.  
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Background  
Anaemia is a very common condition, which leads to a decrease in red blood cells and 
circulating haemoglobin in the blood, resulting in lower oxygen carrying capacity 1. This is 
widely observed among pregnant women in developing countries such as India 1. Anaemia 
leads to conditions such as general fatigue, weakness, shortness of breath 1.  
The National Family Health Survey of India (NFHS 3) reported that 56% of women (between 
15 to 49 years) were anaemic with a greater prevalence in rural areas 2. The high 
prevalence of anaemia in a rural Indian setting is exacerbated by limited medical 
infrastructure to diagnose and treat anaemia 3 4. Poor medical care during pregnancy may 
affect obstetric outcomes such as birth weight 2. If the weight at birth is less than 2.5 kg then 
it is labelled as low birth weight (LBW), which may hamper neonatal health outcomes 2.  The 
NFHS 3 suggested that LBW prevalence is about 22% in the country with higher occurrence 
in rural areas compared to urban regions 2. Higher prevalence was seen in younger women 
(< 20 years) at the time of delivery, and the prevalence decreased with an increase in 
education and wealth 2.  
There is limited information on risk factors for either anaemia during pregnancy or low birth 
weight (LBW) from rural areas of India. A community based cohort study to identify 
determinants of LBW was conducted in rural areas of Maharashtra state in 1994 5. In this 
study, an increased risk of LBW was associated with i) low maternal haemoglobin (Hb) (less 
than 9.0 g/dL), ii) third trimestral bleeding, and iii) low maternal body mass index (BMI). 
However, the prevalence and risk factors associated with maternal anaemia were not 
assessed in this study. To our knowledge, no cohort studies on this important public health 
issue have been conducted in rural areas of the country. 
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The aim of this study of pregnant women from rural areas of Maharashtra state of India was 
to estimate the prevalence of anaemia, and investigate associated risk factors during the 
early stages of pregnancy. The study also examined exposures associated with low birth 
weight in the rural population. This research is a part of the project known as ‘Maharashtra 
Anaemia Study’ (MAS).  
 
 
 
 6 
Material and Methods  
 
Study population 
The Maharashtra Anaemia Study (MAS) is a joint collaboration between Halo Medical 
Foundation India (HMF) and the University of Nottingham, United Kingdom (UK) 6. The 
research area included 34 villages (approximately 65,000 population) from Tuljapur and 
Lohara blocks of Osmanabad district. Osmanabad district has a population of 1.6 million 
individuals; 85% reside in rural areas, with a low mean annual income (600 GBP per capita), 
and limited healthcare infrastructure 7. The majority of pregnant women receive obstetric 
care in this community from government healthcare providers such as nurses.  
A pilot process to test the study recruitment and data collection methods was conducted 
from January to March 2014. Study equipment was tested on the 1st working day of each 
month to generate an equipment performance report. The HMF’s hospital in Andur provided 
the laboratory investigation support for this study 8.  
The study was approved by the Institutional Ethics Committee of Government Medical 
College Aurangabad, Maharashtra, India (reference number: Pharma/IEC/GMA/196/2014), 
and the University of Nottingham (UK) Medical School Ethics Committee (reference number: 
E10102013).  
 
Recruitment and data collection  
Data were collected at three stages: (a) pre-delivery data collection from pregnant women 
participants, (b) village level data collection and (c) post-delivery data collection.  
 
 
 7 
(a) Pre-delivery data collection: Pregnant women were identified through monthly household 
surveys of women in the reproductive age group (15 to 49 years), conducted by HMF’s 
village based healthcare workers. All self-reported pregnancies identified between April 1, 
2014 and December 31, 2014 were eligible. No formal sample size calculation was 
conducted, as the project was designed as a feasibility study to inform future research 
priorities. Eligible study participants were approached and provided with a summary of the 
proposed study. Those who decided to enter the study provided written consent before entry 
to the study. 
The questionnaire was administered in the local language by a trained data assistant or the 
primary investigator (PI) himself across the project tenure. The individual questionnaire had 
sections on sociodemographic characteristics, medical/obstetric history, iron supplements, 
vaccinations, dietary preference, 7-day diet recall, family assets, ante-natal care (ANC) 
access and self-reported birth outcomes, in accordance with the standard operating 
procedures (SOP) 9. The blood sample was collected by a trained member of the study 
team. Anthropometric measurements including height and mid-upper arm circumference 
(MUAC) of the dominant hand, were recorded using measuring tapes. Weight was 
ascertained using a digital weighing machine (OMRON Healthcare, India). Blood pressure 
(BP) was measured using the right arm in a sitting position with an automated digital BP 
monitor following manufacturer’s recommendations (OMRON Healthcare, India). Venous 
blood withdrawal was performed in a supine position by a qualified and a trained laboratory 
technician. The complete blood count (CBC) was measured using Sysmex XP-100 
automated analyser (Sysmex Corporation, Japan), and random blood sugar (RBS) was 
calculated using semi-automated device Erba Chem Touch (Erba Mannheim, Germany) at 
HMF hospital. All data collection and investigation were performed in the presence of the 
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PI.Additional information on data collection, blood withdrawal, transport, investigation and 
quality controls is published elsewhere 10.  
Anaemia was defined based on a haemoglobin (Hb) level of less than 11.0 g/dL, and 
additionally further categorisation is performed using Hb levels as follows: severe anaemia 
(Hb < 7.0 g/dL), moderate anaemia Hb 7.0 to 9.9 g/dL, and mild anaemia (Hb 10.0 to 10.9 
g/dL) 11. LBW was defined as baby weight less than 2.5 kilograms (Kg) at birth 12. Diabetes 
was defined as RBS ≥ 200 mg/dL 13. Any pathological changes in white blood cells, platelets 
and red blood cells reported by the Sysmex XP-100 analyser were recorded. Hypertension 
was diagnosed if the mean of two consecutive measurements was more than 140/90 mm of 
Hg 14. Consanguineous marriage was defined as an union between two individuals such as 
second cousins or closer who share blood relatives 15. 
 
(b) Village level data collection:  The village profile included information on village based 
healthcare facilities, infrastructure such as water supplies and transport resources, and data 
were obtained from HMF’s village health workers (VHWs), government nurses and local 
government offices.  
 
(c) Post-delivery data collection: All participants were followed up through HMF’s village 
health workers network, and were also contacted twice during their pregnancy over the 
telephone to inquire about their wellbeing. Post-delivery data were collected by a telephone 
call to the participants within one week of delivery. Data were collected on the number of 
hospital visits during pregnancy, any disease/condition diagnosed following the baseline 
recruitment, blood transfusion, delivery location (hospital/home), delivery type 
(normal/assisted/caesarean), birth weight and information on any maternal/neonatal 
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complications. Birth weight data were obtained from post-natal health records for in-hospital 
deliveries, and for home deliveries, weight was recorded within the first two hours of birth at 
the nearest health centre. Post-delivery data collection was completed on 30th June 2015.  
 
Data analysis  
Analysis was performed using Stata statistical software (v13.1, Texas, USA).   
Pre-delivery data: Logistic regression was performed to investigate the association between 
the risk factors and maternal anaemia (binary variable). Linear regression was used to 
investigate the association between potential risk factors and maternal Hb levels (continuous 
variable).  
Village data: Village level risk factors were also investigated for the risk of anaemia using 
both linear and logistic regression.  
Post –delivery data: Logistic regression was performed to investigate the association 
between the risk factors and low birth weight (binary variable). Linear regression was used 
to investigate the association between maternal covariates and birth weight (continuous 
variable).  
Multivariable analysis: For the models, covariates were selected based on their theoretical 
relationship with maternal anaemia based on both our understanding of the study setting 
and the published literature. This resulted in three groups of covariates for the three main 
analyses conducted in this study (Figure 1). Initially unadjusted analysis to study the 
association of individual covariates with the outcome of interest was carried out for all three 
analyses outlined above. The final model was built using a parsimonious stepwise approach 
that combined all univariate associations with a P value of less than 0.05, discarding 
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any where the P value increased to >0.05 in the multivariable model. A fully adjusted 
analysis used all factors in each of the three groups of covariates (Figure 1) to determine the 
robustness of the observations detected. Due to multicollinearity between height, weight, 
and calculated body mass index, MUAC was the only anthropocentric measurement 
included in the model.  
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Results  
(a) Pre-delivery data findings: During the recruitment period (8 months), we identified 303 
pregnant women from 34 villages, of whom 287 (95%) aged 15 to 36 years provided 
complete data (Figure 2). The overall anaemia prevalence was 77% (N=221, Hb < 11.0 
g/dL); 3% had severe anaemia (Hb < 7.0 g/dL), 38% had moderate anaemia (Hb: 7.0 to 9.9 
g/dL), and 36% had mild anaemia (Hb: 10 to 10.9 g/dL). About 26% (N=75), were teenage 
pregnancies (maternal age ≤19 years), and anaemia prevalence did not vary by maternal 
age (Table 1). The majority of women (67%) had a normal BMI (18.5 to 24.9 kg/m2), while 
28% were underweight (BMI < 18.5 kg/m2). Of 287, 85 participants (29.6%) were in 
consanguineous marriage relationship.  
The mean Hb was 10.5 g/dL (Standard Deviation (SD): 1.29, Range: 5.5 to 14), and Hb 
values followed a normal distribution (Supplementary Figure 1a). The average mean 
corpuscular volume (MCV) was 80.5 fl/cell, (SD: 7.22, Range 53.4 to 93.8) (Supplementary 
Figure 1b) 16. Other Red Blood Cell indices are detailed in the Supplementary Table 1. No 
abnormalities relating to white blood cells and platelets were detected. None of the 
participants reported any history of a systemic disease/treatment (such as malaria, blood 
transfusion, diabetes, hypertension) in the previous 12 months at the time of recruitment.  A 
consanguineous marriage was the only risk factor associated with anaemia in both 
unadjusted and adjusted analysis (adjusted Odds Ratio (OR): 2.41, 95% Confidence Interval 
(CI): 1.16 to 5.01, P = 0.01) (Tables 1 and 4).  
 
(b) Village level data findings: All villages (N=34) were allocated government nurses. The 
majority (N=29) were visited by nurses once a month for ANC check-ups (providing 
vaccinations and IFA supplementation), while in the remaining 5 villages, pregnant women 
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had daily access to healthcare staff stationed in the same village. Normal obstetric delivery 
facilities were available in one village only. Of 34 villages, piped water supplies were 
available in 24 villages, and 11 villages had operational community toilets. Our study area 
had limited transport services to the nearest secondary care hospitals, and was mostly 
serviced by private vehicle operators. Daily access to a government nurse was the only 
factor associated with a lower risk of anaemia in the unadjusted analysis (OR: 0.48, 95% CI: 
0.25 to 0.93, P =0.03) (Table 2), although this association did not persist in the multivariable 
analysis adjusting for all possible confounding factors (Table 4). 
 
(c) Post-delivery data findings: There were 86% (N=248) full-term singleton live births 
(Figure 3). Of 35 complications identified in the post-delivery data (Figure 3), 11 participants 
were in consanguineous relationships, among whom 7 preterm deliveries, 2 stillbirths and 2 
neonatal deaths were recorded. No maternal deaths were recorded. None of the participants 
were diagnosed with systemic conditions such as hypertension or diabetes during 
pregnancy.  
Of 248 full-term singleton live births, 211 (85%) were uncomplicated vaginal deliveries and 
37 (15%) were caesarean sections. In total, 236 participants (95%) delivered in a healthcare 
facility, and the remaining 12 (5%) were home deliveries (Table 3). There were 18 (7%) 
LBW babies, and the mean birth weight was 2.89 Kg (SD: 0.42 Kg). About 49.6% (123/248) 
were female births. No association was seen in the odds of LBW or mean birth weight by 
baby’s gender. There was a higher likelihood of LBW among women who had a 
consanguineous marriage (adjusted OR: 4.10, 95% CI: 1.25 to 13.41, P =0.02) compared to 
those who did not. The presence of maternal anaemia in the third to fifth months of 
pregnancy was associated with lower risk of LBW (unadjusted OR: 0.34, 95% CI: 0.13 to 
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0.92, P = 0.03). The association of anaemia was consistent after adjusting for 
consanguineous marriage (OR: 0.25, 95% CI: 0.09 to 0.73, P =0.01). On conducting a linear 
regression of two continuous variables of interest, birth weight (outcome) and maternal 
haemoglobin (exposure), a borderline association was observed (β coefficient: -0.36 Kg, 
95% CI: -0.74 to 0.02, P =0.06). 
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Discussion 
A high prevalence of anaemia (77%) was observed in pregnant women living in rural 
Maharashtra during the third to fifth months of pregnancy. Consanguineous marriage was a 
potentially avoidable risk factor for both maternal anaemia and LBW. Maternal anaemia was 
associated with a lower risk of LBW. In addition, limited access to an antenatal nurse was 
associated with a higher likelihood of anaemia.  
 
Strengths and limitations   
This is the first prospective study involving Indian rural population, which investigated both 
individual and community level risk factors for maternal anaemia and birth outcomes. While 
operating in challenging remote areas, our ability to conduct recruitment, venous blood 
investigations, quality controls, and participant follow-up are major strengths of the study. 
However, we were unable to perform more detailed measurements on obstetric 
observations such as haematinic blood tests or in utero growth using ultrasound imaging 
due to limited resources. Another limitation is that the women were recruited over a range of 
pregnancy time points (i.e. between the third and fifth month). As anaemia is a normal 
physiological response to pregnancy over this period, defining anaemia is challenging, while 
comparing women at slightly different points during pregnancy may have introduced some 
non-differential bias to our analysis. Risk factors associated with maternal anaemia in rural 
population may differ from those in urban communities because of differences in health 
service access, socioeconomic status and environmental conditions, which may impact on 
the generalizability of these observations.  Finally we did not have the ability to measure 
detailed haematinic micronutrients such as vitamin B12, folate and iron to investigate the root 
causes of anaemia. 
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Synthesis  
In the Indian national family health surveys (NFHS-2 and NFHS-3), pregnant women from all 
stages/trimesters were included in the anaemia assessment 17 . Results from the NFHS 2 
(1998-99, N= 5619 pregnancies from 28 Indian states) reported an overall prevalence of 
anaemia of 47%, with mainly mild and moderate anaemic cases 18. Findings from the NFHS 
3 (2005-06) reported an increase in anaemia prevalence (59%, N= 6028 pregnant 
women)19. Our study reported a higher prevalence compared to both NFHSs. These surveys 
showed that the prevalence varied across and within Indian states suggesting the influence 
of local lifestyles and cultural norms, individual medical conditions, infrastructure, and 
healthcare services. For example, a study in a remote north-eastern region (Assam State) 
reported a prevalence of 90% with major difference in birth weight among anaemic and non-
anaemic women 20. Our study from Central India reported a high anaemia prevalence in 
pregnancy, where lower risk of LBW was observed in anaemic mothers compared to non-
anaemic. The findings should be interpreted cautiously, as our study had a smaller sample 
size, and further research is essential to confirm such association. Published studies from 
Maharashtra state showed a 30% to 65% anaemia prevalence in pregnancy with higher 
prevalence in rural regions 2,5,21,22. Studies from South India found 55% to 60% anaemia 
among pregnant women in a region where consanguineous marriage is a common practice 
15. 
 
A recent Indian Human Development Survey reported a national prevalence of 16% of 
consanguineous marriages, with a higher occurrence in Maharashtra state (28%) 15. In such 
relationships, the maternal cousin (maternal uncle’s son) is the most preferred partner in our 
study area, and these marriages are favoured due to local cultural and economic reasons.  
 
 
 16 
Currently there is no other published evidence on the association between consanguinity 
and maternal anaemia and this needs further independent investigation. 
Findings from one of the oldest Indian studies showed that on an average babies born to 
consanguineous participants weighed 0.25 Kg less than babies from non-consanguineous 
relationships 23. However, this observation was limited to poor socioeconomic groups when 
compared with participants from higher socioeconomic class. Findings from the prospective 
cohort of pregnant women (N=601) in rural regions of Karnataka state showed an increase 
in LBW incidence among consanguineous couples (P =0.04) 24. The study also showed 
higher risks of stillbirth associated with consanguinity.  A recent 2013 cross-sectional 
analysis from Karnataka state reported higher risk of LBW with consanguineous marriages 
25. Findings from these three Indian studies are in agreement with our results. Similarly, 
studies from Lebanon, Qatar, Pakistan and Jordan have reported higher risks of LBW in 
consanguineous relationship 26–29. In consanguineous couples, a study from Lebanon 
reported a 1.8% decrease in birth weight 26, full term babies born in Qatar were nearly twice 
as likely to be LBW 27, the study from Pakistan showed 14% higher risk of small babies 28. 
Analysis of the village level data showed lower likelihood of maternal anaemia associated 
with regular access to government nurses who conduct routine ANC checks-ups, provide 
vaccinations and free IFA supplies. In villages where nurses were permanently stationed, 
improved access to such services, compared to remote villages receiving monthly visits 
could explain this association. Alternatively, there are many environmental factors that may 
contribute to residual confounding.  
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Conclusion  
The prevalence of anaemia during the third to fifth months of pregnancy in a rural population 
living in Maharashtra State was 77%. Consanguineous marriage was identified as a risk 
factor of maternal anaemia and low birth weight. Anaemia prevalence remained higher in the 
recent NFHS survey (2005-06) compared to the earlier survey data (1998-99) 2. There is an 
urgent need for further research into clinical causes and optimal definitions of anaemia in 
Indian population, which can inform the design and implementation of suitable interventions. 
Lastly, community education on anaemia and impacts of consanguineous marriages may 
help in improving reproductive health outcomes.
 
 
 18 
References 
1.  World Health Organisation. Anaemia. Available at: 
http://www.who.int/topics/anaemia/en/ (Accessed on 22 June 2016). 
2.  National Family Health Survey. Available at: http://rchiips.org/nfhs/ 
(Accessed on 15 June 2016). 
3.  Pasricha SR, Biggs BA, Prashanth NS, Sudarshan H et al. Factors 
influencing receipt of iron supplementation by young children and their 
mothers in rural India: local and national cross-sectional studies. BMC 
Public Health. 2011;11:617.  
4.  Chaturvedi S, Ranadive B. Are we really making motherhood safe? A 
study of provision of iron supplements and emergency obstetric care in 
rural Maharashtra. Natl Med J India 2007. 20:294-296.  
5.  Hirve SS, Ganatra BR. Determinants of low birth weight: a community 
based prospective cohort study. Indian Pediatr 1994;31:1221-1225.  
6.  World Health Organisation. Postpartum care of the mother and 
newborn: a practical guide. Available at: 
http://www.who.int/maternal_child_adolescent/documents/who_rht_ms
m_983/en/ (Accessed on 10 June 2016). 
7.  Government of Maharashtra. Osmanabad District Report 2013. 
Available at: 
https://mahades.maharashtra.gov.in/homePage.do?actionPage=1 
(Accessed on 25 June 2016). 
8.  Halo Medical Foundation. Available at: 
http://www.halomedicalfoundation.org/ (Accessed on 13 May 2016). 
9.  Standard Operating Procedure and Conduct Guidelines Anaemia 
Control Project (Maharashtra Anaemia Study). Available at:  
http://www.slideshare.net/dranandahankari/standard-operating-
procedure-and-conduct-guidelines-anaemia-control-project-hmf-india 
(Accessed on 15 May 2016). 
10.  Ahankari AS, Fogarty AW, Tata LJ, Dixit JV et al. Assessment of a non-
invasive haemoglobin sensor NBM 200 among pregnant women in rural 
India. BMJ Innovations 2016. doi:10.1136/bmjinnov-2015-000085. 
11.  Governnment of India. Iron deficiency anameia control guidelines. 
Available at: http://nrhm.gov.in/nrhm-components/rmnch-a/child-health-
immunization/child-health/guidelines.html. (Accessed on 15 May 2016). 
12.  Wilcox AJ. On the importance and the unimportance of birthweight. Int J 
Epidemiol 2001;30:1233-1241.   
13.  World Health Organisation. Definition and diagnosis of diabetes mellitus 
and intermediate hyperglycaemia. Available at: 
http://www.who.int/diabetes/publications/Definition and diagnosis of 
diabetes_new.pdf. (Accessed on 25 May 2016). 
14.  Whitworth JA. 2003 World Health Organization (WHO)/International 
Society of Hypertension (ISH) statement on management of 
hypertension. J Hypertension 2003;21:1983-1992.  
15.  Kuntla S, Student MP, Goli S, Arokiasamy P. Revisiting 
Consanguineous Marriages and their Effect on Pregnancy Outcomes in 
India: Evidences from a Nation-wide Survey. Availbale at: 
http://paa2012.princeton.edu/papers/121292 (Accessed on 1 May 
2016).  
 
 
 19 
16.  Walker HK, Hall WD, Hurst JW (eds). Clinical Methods: The History, 
Physical,  and Laboratory Examinations. 3rd edition. Boston: Butterworths; 
1990. 
17.  International Institute for, Population Sciences (IIPS) and ORC Macro. 
National Family Health Survey (NFHS-2), 1998–99: India. Available at: 
http://www.dhsprogram.com/pubs/pdf/FRIND2/FRIND2.pdf. (Accessed 
on 5 May 2016).  
18.  Bharati P, Som S, Chakrabarty S, Bharati S et al. Prevalence of anemia 
and its determinants among nonpregnant and pregnant women in India. 
Asia Pac J Public Health. 2008;20:347-359.  
19.  International Institute for Population, Sciences (IIPS) and Macro 
International. National Family Health Survey (NFHS-3). Available at: 
http://dhsprogram.com/pubs/pdf/FRIND3/FRIND3-Vol1%5BOct-17-
2008%5D.pdf. (Accessed on 5 May 2016).  
20.  Bora R, Sable C, Wolfson J, Boro K et al. Prevalence of anemia in 
pregnant women and its effect on neonatal outcomes in Northeast India. 
J Matern Fetal Neonatal Med 2014;27:887-891.  
21.  Mumbare SS, Maindarkar G, Darade R, Yenge S et al. Maternal risk 
factors associated with term low birth weight neonates: a matched-pair 
case control study. Indian Pediatr 2012;49:25-28.  
22.  Haralkar SJ, Khandekar SV, Pore PD, Haralkar AS et al. Socio-
Demographic Correlates of Anaemia among Married Women in Rural 
Area of Maharashtra. Indian J Public Heal Res Dev 2013;4:107-110.  
23.  Kulkarni ML, Kurian M. Consanguinity and its effect on fetal growth and 
development: a south Indian study. J Med Genet 1990;27:348-352.  
24.  Bellad MB, Goudar SS, Edlavitch SA, Mahantshetti NS et al. 
Consanguinity, prematurity, birth weight and pregnancy loss: a 
prospective cohort study at four primary health center areas of 
Karnataka, India. J Perinatol 2012;32:431-437.  
25.  Joseph N, Pavan KK, Ganapathi K, Apoorva P et al. Health awareness 
and consequences of consanguineous marriages: a community-based 
study. J Prim Care Community Health 2015;6:121-127.  
26.  Mumtaz G, Tamim H, Kanaan M, Khawaja M et al. Effect of 
consanguinity on birth weight for gestational age in a developing 
country. Am J Epidemiol 2007;165:742-752. 
27.  Bener A, Saleh NM, Salameh KMK, Basha B et al. Socio-demographic 
and consanguinity risk factors associated with low birthweight. J Pak 
Med Assoc 2013;63:598-603.  
28.  Zakar R, Zakar MZ, Aqil N. Adverse birth outcomes associated with 
consanguineous marriage in Pakistan. Int J Gynaecol Obstet 
2014;127:211.  
 
 
 
 20 
Table 1: Pre-delivery data: individual risk factors associated with maternal anaemia during pregnancy (linear and logistic 
regression, N= 287 pregnant women) 
Characteristics All study participants 
N (%) 
Anaemic participants 
N (% with anaemia for 
each level of risk factor) 
Unadjusted linear 
regression 
β (95% CI) (Hb in g/dL) 
Unadjusted logistic 
regression 
OR (95% CI) 
Maternal age     
Up to 19 years 75 (26.1) 61 (81.3) 0.01 (-0.04 to 0.06) 0.94 (0.86 to 1.03) 
20 and above 212 (73.8) 160 (75.4) - - 
Religion and category     
Hindu open category 137 (47.7) 106 (77.3) Reference Reference 
Hindu reserved category 127 (44.2) 99 (77.9) -0.06 (-0.38 to 0.25) 1.03 (0.57 to 1.84) 
Muslim 23 (8.0) 16 (69.5) 0.15 (-0.42 to 0.73) 0.66 (0.25 to 1.77) 
Annual income (in GBP)     
≤ 500 137 (47.7) 104 (75.9) Reference Reference 
Between 501 to 1000 129 (44.9) 100 (77.5) 0.03 (-0.28 to 0.35) 1.09 (0.61 to 1.93) 
≥ 1001  21 (7.3) 17 (80.9) 0.10 (-0.49 to 0.70) 1.34 (0.42 to 4.29) 
Mid-upper arm 
circumference of 
dominant hand (MUAC) 
    
< 22 cm 25 (8.7) 19 (76.0) Reference Reference 
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≥ 22 cm 262 (91.2) 202 (77.0) 0.26 (-0.27 to 0.80) 1.06 (0.40 to 2.78) 
Currently consuming 
Iron Folic Acid 
supplements 
    
No 74  (25.7) 55 (74.3) Reference Reference 
Yes 213  (74.2) 166 (77.9) -0.17 (-0.52 to 0.17) 1.22 (0.66 to 2.25) 
Gravidity      
1 128 (44.6) 102 (79.6) -0.04 (-0.21 to 0.12) 0.98 (0.73 to 1.34) 
2 103 (35.8) 73 (70.8) - - 
3 or more 56 (19.5) 46 (82.1) - - 
Diet recall (recent 7 
days history) 
    
Pure milk (not in the 
form of tea/coffee) 
    
≤ 2 times a week 159 (55.4) 122 (76.7) Reference Reference 
≥ 3 times a week 128 (44.6) 99 (77.3) 0.10 (-0.19 to 0.41) 1.03 (0.59 to 1.80) 
Green leafy vegetables     
≤ 2 times a week 165 (57.4) 130 (78.7) Reference Reference 
≥ 3 times a week 122 (42.5) 91 (74.5) -0.01 (-0.31 to 0.29) 0.79 (0.45 to 1.37) 
Bean sprouts     
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≤ 2 times a week 278 (96.8) 214 (76.9) Reference Reference 
≥ 3 times a week 9 (3.1) 7 (77.7) 0.28 (-0.58 to 1.15) 1.04 (0.21 to 5.16) 
Pulses-lentils     
≤ 2 times a week 74 (25.7) 59 (79.7) Reference Reference 
≥ 3 times a week 213 (74.2) 162 (76.0) 0.06 (-0.28 to 0.40) 0.80 (0.42 to 1.54) 
Fruits/Fruit juices     
≤ 2 times a week 154 (53.6) 118 (76.6) Reference Reference 
≥ 3 times a week 133 (46.3) 103 (77.4) -0.17 (-0.47 to 0.13) 1.04 (0.60 to 1.81) 
Rice     
≤ 2 times a week 20 (6.9) 16 (80) Reference Reference 
≥ 3 times a week 267 (93.0) 205 (76.7) 0.30 (-0.29 to 0.89) 0.82 (0.26 to 2.56) 
Eggs     
≤ 2 times a week 271 (94.4) 209 (77.1) Reference Reference 
≥ 3 times a week 16 (5.5) 12 (75) 0.16 (-0.50 to 0.82) 0.88 (0.27 to 2.85) 
Chicken     
≤ 2 times a week 279 (97.2) 214 (76.7) Reference Reference 
≥ 3 times a week 8 (2.7) 7 (87.5) -0.20 (-1.12 to 0.72) 2.12 (0.25 to 17.60) 
Goat/fish meat     
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≤ 2 times a week 284 (98.9) 219 (77.1) Reference Reference 
≥ 3 times a week 3 (1.0) 2 (66.6) 0.92 (-0.56 to 2.42) 0.59 (0.05 to 6.65) 
Education completed     
Primary school 170 (59.2) 132 (77.6) Reference Reference 
Secondary school  69 (24.0) 54 (78.2) 0.02 (-0.34 to 0.39) 1.03 (0.52 to 2.03) 
≥ Higher secondary 
school  
48 (16.7) 35 (72.9) 0.02 (-0.39 to 0.44) 0.77 (0.37 to 1.61) 
Consanguineous 
marriage  
    
No 202 (70.3) 148 (73.2) Reference Reference 
Yes 85 (29.6) 73 (85.8) -0.00 (-0.34 to 0.32) 2.21 (1.11 to 4.40)* 
Current pregnancy 
registration  
at health facility 
    
No 18 (6.2) 14 (77.7) Reference Reference 
Yes 269 (93.7) 207 (76.9) 0.14 (-0.48 to 0.77) 0.95 (0.30 to 3.00) 
 
Table 1 footnotes:  * indicates P <0.05.  For linear regression, haemoglobin values were used as a continuous measure (main 
outcome), and in the logistic regression anaemic or non-anaemic status was the main outcome. OR=odds ratio, β=linear regression 
correlation coefficient, CI= confidence interval Annual income is expressed in Great Britain Pound (GBP). 1 GBP was calculated as 
being equivalent to 100 INR. Maternal age and gravidity used as a continuous variable following linearity assessment.
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Table 2: Village level data: Community risk factors associated with anaemia during pregnancy (linear and logistic 
regression, N= 287 pregnant women from 34 villages) 
Village 
Characteristics 
Village frequency 
(%) 
All study 
participants 
N (%) 
Anaemic 
participants 
N (% with anaemia 
for 
each level of risk 
factor) 
Unadjusted linear 
regression 
β (95% CI) (Hb in 
g/dL) 
Unadjusted 
logistic 
regression OR 
(95% CI) 
Piped water 
supplied to 
houses 
     
No 10 (29.4) 68 (23.6) 50 (73.5) Reference Reference 
Yes 24 (70.5) 219 (76.3) 171 (78.0) -0.22 (-0.58 to 
0.13) 
1.28 (0.68 to 2.40) 
Daily water supply 
(at least once a 
day) 
     
No 7 (20.5) 56 (19.5) 46 (82.1) Reference Reference 
Yes 27 (79.4) 231 (80.4) 175 (75.7) 0.24 (-0.14 to 0.62) 0.67 (0.32 to 1.43) 
Operational 
community toilets 
     
No 23 (67.6) 122 (42.5) 99 (81.1) Reference Reference 
Yes 11 (32.3) 165 (57.4) 122 (73.9) 0.10 (-0.20 to 0.40) 0.65 (0.37 to 1.16) 
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Government 
health center 
availability 
     
No 24 (70.5) 177 (61.6) 141 (79.6) Reference Reference 
Yes 10 (29.4) 110 (38.3) 80 (72.7) 0.22 (-0.08 to 0.54) 0.68 (0.39 to 1.18) 
Accredited social 
health attendant 
(ASHA) appointed 
     
No 1 (2.9) 6 (2.0) 4 (66.6) Reference Reference 
Yes 33 (97.0) 281 (97.9) 217 (77.2) -0.95 (-2.01 to 
0.10) 
1.69 (0.30 to 9.46) 
Daily access to 
government nurse 
     
No 29 (85.2) 235 (81.8) 187 (79.5) Reference Reference 
Yes 5 (14.7) 52 (18.1) 34 (65.3) 0.24 (-0.14 to 0.63) 0.48 (0.25 to 0.93)* 
Government 
nurse provides 
antenatal care 
services 
     
No 1 (2.9) 6 (2.0) 4 (66.6) Reference Reference 
Yes 33 (97.0) 281 (97.9) 217 (77.22) 0.45 (-0.60 to 1.51)  1.69 (0.30 to 9.46) 
Government 
nurse conducts 
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haemoglobin 
investigation 
No 8 (23.5) 68 (23.6) 54 (79.4) Reference Reference 
Yes 26 (76.4) 219 (76.3) 167 (76.2) -0.13 (-0.49 to 
0.22) 
0.83 (0.42 to 1.61) 
Private doctor 
availability 
     
No 31 (91.1) 236 (82.2) 184 (77.9) Reference Reference 
Yes 3 (8.8) 51 (17.7) 37 (72.5) 0.34 (-0.04 to 0.74) 0.74 (0.37 to 1.48) 
Travel time to 
nearest hospital 
Continuous 
variable 
- - -0.00 (-0.00 to 
0.01) 
1.00 (0.98 to 1.02) 
 
Table 2 footnotes: * indicates P <0.05. For linear regression, haemoglobin values were used as a continuous measure (main 
outcome), and in the logistic regression anaemic or non-anaemic status was the main outcome. OR= Odds ratio, β=linear 
regression correlation coefficient, CI= confidence interval.
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Table 3: Post-delivery data: individual risk factors associated with low birth weight (linear and logistic regression, N= 248 
pregnant women) 
Characteristics All study 
participants 
N (%) 
Low birth weight 
babies 
N (% with LBW for 
each level of risk 
factor) 
Unadjusted linear 
regression 
β (95% CI) [birth 
weight in Kg] 
Unadjusted logistic 
regression 
OR (95% CI) 
Maternal age 248 (100) 18 (7.2) 0.00 (-0.01 to 0.01) 0.98 (0.83 to 1.16) 
Religion and category     
Hindu open category 
Hindu reserved category 
128 (51.6) 
105 (42.3) 
8 (6.2) 
9 (8.5) 
Reference  
0.01 (-0.09 to 0.12) 
Reference  
1.40 (0.52 to 3.78) 
Muslim 15 (6.0) 1 (6.6) 0.10 (-0.12 to 0.33) 1.07 (0.12 to 9.20) 
Annual income     
≤ 500 GBP 
Between 501 and 1000 GBP 
113 (45.5) 
117 (47.1) 
8 (7.0) 
10 (8.5) 
Reference  
-0.05 (-0.16 to 0.05) 
Reference  
1.22 (0.45 to 3.22) 
≥ 1001 GBP 18 (7.2) 0 0.06 (-0.15 to 0.27) Omitted 
Mid-upper arm circumference of 
dominant hand (MUAC) 
    
< 22 22 (8.8) 2 (9.0) Reference  Reference  
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≥ 22 cm 226 (91.1) 16 (7.0) 0.11 (-0.06 to 0.30) 0.76 (0.16 to 3.55) 
Currently consuming Iron Folic 
Acid supplements 
    
No 
Yes 
58 (23.3) 
190 (76.6) 
7 (12.0) 
11 (5.7) 
Reference  
0.05 (-0.06 to 0.18) 
Reference  
0.44 (0.16 to 1.21) 
Gravidity 248 (100) 18 (7.2) 0.02 (-0.03 to 0.07) 0.79 (0.44 to 1.41) 
Diet recall (recent 7-days 
history) 
    
Pure milk (not in the form of 
tea/coffee) 
    
≤ 2 times a week 
≥ 3 times a week 
134 (54.0) 
114 (45.9) 
14 (10.4) 
4 (3.5) 
Reference  
0.03 (-0.07 to 0.14) 
Reference  
0.31 (0.09 to 0.97)* 
Green leafy vegetables     
≤ 2 times a week 
≥ 3 times a week 
140 (56.4) 
108 (43.5) 
14 (10) 
4 (3.7) 
Reference  
0.04 (-0.06 to 0.14) 
Reference  
0.34 (0.11 to 1.08) 
Bean sprouts     
≤ 2 times a week 
≥ 3 times a week 
241 (97.1) 
7 (2.8) 
18 (7.4) 
0 
Reference  
0.04 (-0.28 to 0.36) 
Reference  
Omitted 
Pulses-lentils     
≤ 2 times a week 69 (27.8) 6 (8.6) Reference  Reference  
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≥ 3 times a week 179 (72.1) 12 (6.7) 0.07 (-0.04 to 0.19) 0.75 (0.27 to 2.09) 
Fruits/Fruit juices     
≤ 2 times a week 
≥ 3 times a week 
134 (54.0) 
114 (45.9) 
13 (9.7) 
5 (4.3) 
Reference  
0.08 (-0.01 to 0.19) 
Reference  
0.42 (0.14 to 1.23) 
Rice     
≤ 2 times a week 
≥ 3 times a week 
18 (7.2) 
230 (92.7) 
3 (16.6) 
15 (6.5) 
Reference  
0.03 (-0.16 to 0.24) 
Reference  
0.34 (0.09 to 1.33) 
Eggs     
≤ 2 times a week 
≥ 3 times a week 
234 (94.3) 
14 (5.6) 
17 (7.2) 
1 (7.1) 
Reference  
0.07 (-0.15 to 0.30) 
Reference  
0.98 (0.12 to 7.69) 
Chicken     
≤ 2 times a week 
≥ 3 times a week 
242 (97.5) 
6 (2.4) 
18 (7.4) 
0 
Reference  
0.31 (-0.02 to 0.66) 
Reference  
Omitted 
Goat/fish meat     
≤ 2 times a week 
≥ 3 times a week 
247 (99.5) 
1 (0.5) 
18 (7.2) 
0 
Reference  
-0.39 (-1.23 to 0.44) 
Reference  
Omitted 
Education completed     
Primary school 138 (55.6) 13 (9.4) Reference  Reference  
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Table 3 footnotes:  * indicates P <0.05. Birth weight is used as a continuous measure in linear regression, and in the logistic 
regression it is classified as a binary categorical variable (LBW and non-LBW). Birth weight unit used: kilograms (Kg). OR= Odds 
ratio, β=linear regression correlation coefficient, CI= confidence interval. Income 1 Great Britain Pound (GBP) was considered 
equivalent to 100 Indian Rupees. Maternal age and gravidity used as a continuous variable following linearity assessment. 
Secondary school 66 (26.6) 5 (7.5) 0.00 (-0.12 to 0.12) 0.78 (0.26 to 2.31) 
≥ Higher secondary school 44 (17.7) 0 0.07 (-0.07 to 0.21) Omitted 
Consanguineous marriage     
No 
Yes 
175 (70.5) 
73 (29.4) 
8 (4.5) 
10 (13.6) 
Reference  
-0.11 (-0.23 to -0.00)* 
Reference  
3.13 (1.25 to 8.77)* 
Current pregnancy registration 
at health facility 
    
No 
Yes 
15 (6.0) 
233 (93.9) 
0 
18 (7.7) 
Reference  
0.03 (-0.19 to 0.25) 
Reference  
Omitted 
Maternal anaemia status  
(Hb <11.0 g/dL) 
    
Not anaemic 58  (23.3) 8 (13.7) Reference Reference 
Anaemic 190 (76.6) 10 (5.2) 0.21 (0.08 to 0.33)* 0.34 (0.13 to 0.92)* 
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Table 4: Adjusted logistic regression analysis results for factors 
associated with maternal anaemia and low birth weight 
Analysis  Risk factor Unadjusted  
OR (95% CI) 
Fully adjusted 
OR (95% CI) 
a. Individual 
risk factors 
associated 
with anaemia 
during 
pregnancy  
 
Consanguineous 
marriage 
2.21 (1.11 to 
4.40)* 
2.41 (1.16 to 
5.01)*a 
b. 
Community 
risk factor 
associated 
with anaemia 
during 
pregnancy 
 
Daily access to 
government 
nurse ^ 
0.48 (0.25 to 
0.93)* 
0.48 (0.19 to 
1.19)* b 
c. Individual 
risk factors 
associated 
with low birth 
weight 
Consanguineous 
marriage 
3.13 (1.25 to 
8.77)* 
4.10 (1.25 to 
13.41)*a 
 
Table 4 footnotes: * indicates P values <0.05. OR= Odds ratio, CI= 
confidence intervals. Details of adjustments made are shown below.  
a Indicates adjusted results for maternal age, MUAC, IFA, gravidity, 7-day 
dietary recall, maternal education, religion, pregnancy registration with health 
facility and income.  
b Indicates adjusted results for sanitation facilities (village water supplies, 
toilets), health facilities (government health centre, ASHA, private doctor, ANC 
care, Hb testing services, private doctor availability, travel time to hospital).  
^ Access to government nurse was the associated factors in the unadjusted 
analysis (Table 2 community risk factor group), however on full adjustments 
no associations were observed. 
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Figure 1: Modelling strategy for linear and logistic regression analyses  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pre delivery data- Individual risk factors for maternal anaemia 
assessment 
 
Individual factors included in the regression analyses for anaemia risk 
assessment (10 covariates, outcome- maternal anaemia):  Maternal age, 
mid upper arm circumference (MUAC), currently consuming IFA 
supplementation, gravidity, 7-days diet recall, education completed, 
consanguineous marriage, current pregnancy registration at health facility, 
religion/category and annual income.  
 
 
Village level data- Community risk factors for maternal anaemia 
assessment 
 
Community risk factors included in the regression analyses (10 covariates, 
outcome- maternal anaemia): Water supplies, community toilets, 
government health centre, access to ASHA worker, availability of 
government nurse, services provided by the government nurse (Hb 
investigation, ANC), access to private doctor and travel time to nearby 
hospital.   
 
Post-delivery data- Individual risk factors for low birth weight 
assessment 
 
Individual factors included in the regression analyses for the birth weight 
assessment (10 covariates, outcome- low birth weight):  Maternal age, mid 
upper arm circumference, currently consuming IFA supplementation, 
gravidity, 7-days diet recall, education completed, consanguineous marriage, 
current pregnancy registration at health facility, religion/category and annual 
income. 
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Figure 2: Pre-delivery analysis (final sample size N=287) 
 
 
 
 
 
 
 
 
Total eligible population approached 
N=303 pregnant women from 34 villages 
Declined for blood withdrawal (N=9). 
Reason for decline – recently had same 
blood investigation in preceding 7 days 
Data and blood investigation reports 
obtained from 287 participants (N= 287, 
response rate 95%) 
Agreed and participated in data collection 
N=296 
Declined to participate (N=7).  
Reason for declining- 6 were registered 
with private hospitals where blood 
investigations were performed, and 1 did 
not provide any reason 
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Figure 3: Post-delivery analysis (final sample size N=248) 
 
 
 
 
 
 
 
 
 
 
Data and haemoglobin measurement 
obtained from 287 participants (N= 287) 
 
Post-delivery complications 
(N=35) 
Pre-term deliveries= 21, 
Stillbirth=7 and Neonatal 
deaths=6.  
Loss to follow-up=1 
 
Post-delivery data available for birth 
weight analysis from 248 women 
(N=248) 
Number of women delivered= 283 
Pre-delivery complications (N=4)  
Miscarriages = 3, Induced 
abortion due to fetal anomaly= 1 
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Supplementary Table 1: Red Blood Cell (RBC) indices (N= 287, pre-
delivery data) 
Parameter Mean Standard 
Deviation 
Range 
Red Blood Cell Count 3.5 x 106/mm 0.36 2.7 to 4.9 
Haemoglobin (Hb) 10.04 g/dL 1.29 5.5 to 14.0 
Haematocrit 28.7% 2.85 20.2 to 38.5 
Mean Corpuscular 
Haemoglobin  
(MCH) 
28.2 pg/cell 3.63 14 to 35.1 
Mean Corpuscular Volume 
(MCV) 
80.5 fl/cell 7.22 53.4 to 93.8 
Mean Corpuscular 
Haemoglobin Concentration 
(MCHC) 
34.9 g/dL 1.82 26.2 to 38.8 
RBC Distribution Width 42.5 fl 4.26 12.8 to 60.7 
Reticulocytes %  14.3% 2.41 9.4 to 33.2 
 
Supplementary table 1 footnotes:  Measurement units used: RBC count was 
measured in million cells per microliter. Hb and MCHC were measured in 
grams per decilitre. Haemotocrit and Reticulocytes were measured in 
percentages (%). MCH was measured in pictograms per cell (pg/cell), while 
the MCV and RBC width were measured in femtoliteres (fl) per cell. RBS was 
measured in milligram per decilitre.  
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Supplementary Figure 1b Histogram of MCV among pregnant women 
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Supplementary Figure 1a Histogram of Hb distribution in pregnant women
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studies  
 
Paper title: Risk factor for maternal anaemia and low birth weight in pregnant women living 
in rural India: A prospective cohort study 
  
 
Item 
No 
Recommendation (indicated with page numbers of the 
manuscript) 
 Title and abstract 1 (a) Indicate the study’s design with a commonly used term in 
the title or the abstract (Page 1 and 2) 
(b) Provide in the abstract an informative and balanced 
summary of what was done and what was found (Page 1 and 
2) 
Introduction 
Background/rationale 2 Explain the scientific background and rationale for the 
investigation being reported (page 3 and 4) 
Objectives 3 State specific objectives, including any prespecified 
hypotheses (page 3 and 4) 
Methods 
Study design 4 Present key elements of study design early in the paper (page 
5) 
Setting 5 Describe the setting, locations, and relevant dates, including 
periods of recruitment, exposure, follow-up, and data 
collection (page 5 and 6) 
Participants 6 (a) Give the eligibility criteria, and the sources and methods of 
selection of participants. Describe methods of follow-up (page 
5 and 6) 
(b) For matched studies, give matching criteria and number of 
exposed and unexposed  
Variables 7 Clearly define all outcomes, exposures, predictors, potential 
confounders, and effect modifiers. Give diagnostic criteria, if 
applicable 
Data sources/ 
measurement 
8*  For each variable of interest, give sources of data and details 
of methods of assessment (measurement). Describe 
comparability of assessment methods if there is more than 
one group (page 6 and 7) 
Bias 9 Describe any efforts to address potential sources of bias (page 
8) 
Study size 10 Explain how the study size was arrived at (page 5, 10) 
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Quantitative variables 11 Explain how quantitative variables were handled in the 
analyses. If applicable, describe which groupings were chosen 
and why (page 8 and 9) 
Statistical methods 12 (a) Describe all statistical methods, including those used to 
control for confounding (page 8 and 9) 
(b) Describe any methods used to examine subgroups and 
interactions (page 8 and 9) 
(c) Explain how missing data were addressed 
(d) If applicable, explain how loss to follow-up was addressed 
(e) Describe any sensitivity analyses (page 8 and 9) 
Results 
Participants 13* (a) Report numbers of individuals at each stage of study—eg 
numbers potentially eligible, examined for eligibility, 
confirmed eligible, included in the study, completing follow-
up, and analysed (page 10 and 11, and figures 2, 3) 
(b) Give reasons for non-participation at each stage (page 10 
and 11, and figures 2, 3) 
(c) Consider use of a flow diagram (figure 2, 3) 
Descriptive data 14* (a) Give characteristics of study participants (eg demographic, 
clinical, social) and information on exposures and potential 
confounders (page 10) 
(b) Indicate number of participants with missing data for each 
variable of interest (page 11, 12, figure 3) 
(c) Summarise follow-up time (eg, average and total amount) 
(page 11, 12, figure 3) 
Outcome data 15* Report numbers of outcome events or summary measures 
over time (page 11, 12, figure 3) 
Main results 16 (a) Give unadjusted estimates and, if applicable, confounder-
adjusted estimates and their precision (eg, 95% confidence 
interval). Make clear which confounders were adjusted for 
and why they were included (page 10, 11, 12, and Tables 1-3) 
(b) Report category boundaries when continuous variables 
were categorized (page 10, 11, 12, and Tables 1-3) 
(c) If relevant, consider translating estimates of relative risk 
into absolute risk for a meaningful time period 
Other analyses 17 Report other analyses done—eg analyses of subgroups and 
interactions, and sensitivity analyses (page 10, 11, 12, and 
Table 4) 
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Discussion 
Key results 18 Summarise key results with reference to study objectives 
(Page 13) 
Limitations 19 Discuss limitations of the study, taking into account sources of 
potential bias or imprecision. Discuss both direction and 
magnitude of any potential bias (Page 13) 
Interpretation 20 Give a cautious overall interpretation of results considering 
objectives, limitations, multiplicity of analyses, results from 
similar studies, and other relevant evidence (Page 14, 15) 
Generalisability 21 Discuss the generalisability (external validity) of the study 
results (Page 14, 15, 16) 
Other information 
Funding 22 Give the source of funding and the role of the funders for the 
present study and, if applicable, for the original study on 
which the present article is based (additional information will 
appear at the end of the manuscript, submitted as an 
additional file according to the journal requirement) 
 
*Give information separately for exposed and unexposed groups. 
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background and published examples of transparent reporting. The STROBE checklist is best used in 
conjunction with this article (freely available on the Web sites of PLoS Medicine at 
http://www.plosmedicine.org/, Annals of Internal Medicine at http://www.annals.org/, and 
Epidemiology at http://www.epidem.com/). Information on the STROBE Initiative is available at 
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